Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer

Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer

US Patent 12252493 · Granted Mar 18, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Naphthyridine derivatives as PRC2 inhibitors2025
Naphthyridine derivatives as PRC2 inhibitors2025
Naphthyridine derivatives as PRC2 inhibitors2025
Tetrahydropyridopyrimidine pan-KRas inhibitors2025
Azaquinazoline pan-KRas inhibitors2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2025
SOS1 inhibitors2025
SOS1 inhibitors2025
SOS1 inhibitors2025
Combination therapies2025